Chronos Therapeutics Limited

Calculating rank

USPTO Granted Patents = 4

EPO Patents = 2

Forward Citations = 0

Loading Chart...

17 inventors (with patents filed for the assignee):

Susanna Cremonesi (3 out of 9 patents)

Fabrizio Micheli (3 out of 34 patents)

Teresa Semeraro (3 out of 8 patents)

4. Luca Tarsi (2 out of 16 patents)

5. Tim Luker (2 out of 2 patents)

6. Alexandre Akoulitchev (1 out of 15 patents)

7. Colin Philip Leslie (1 out of 13 patents)

8. Karl Richard Gibson (1 out of 25 patents)

9. Elizabeth Jane Mellor (1 out of 5 patents)

10. Michael Youdell (1 out of 2 patents)

11. Romano Di Fabio (1 out of 33 patents)

12. Alfonso Pozzan (1 out of 4 patents)

13. Anitha Nair (1 out of 1 patent)

14. Barbara Bertani (1 out of 10 patents)

15. Luca Raveglia (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 11660293 - Substituted 2-azabicyclo[3.1.1]heptane and 2-azabicyclo[3.2.1]octane derivatives as orexin receptor antagonists (2023-05-30),

2. 9920053 - N-(hetero)aryl-substituted heteroyclic derivatives useful for the treatment of diseases or conditions related to the central nervous system (2018-03-20),

3. 9908897 - Spirocyclic derivatives (2018-03-06),

4. 8628922 - Screening method for cell aging (2014-01-14),

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#46 in Oxford

#3,873 in United Kingdom

Oxford, United Kingdom

Chronos Therapeutics Limited

Forward Citations = 0

17 inventors:

Susanna Cremonesi (3 out of 9 patents)

Fabrizio Micheli (3 out of 34 patents)

Teresa Semeraro (3 out of 8 patents)

4. Luca Tarsi (2 out of 16 patents)

5. Tim Luker (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Chronos Therapeutics Limited. Retrieved from https://idiyas.com/company/chronos-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]